A new stochastic model for subgenomic hepatitis C virus replication considers drug resistant mutants.

A new stochastic model for subgenomic hepatitis C virus replication considers drug resistant mutants.

As an RNA virus, hepatitis C virus (HCV) is able to rapidly acquire drug resistance, and for this reason the design of effective anti-HCV drugs is a real challenge. The HCV subgenomic replicon-containing cells are widely used for experimental studies of the HCV genome replication mechanisms, for dru...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nikita V Ivanisenko, Elena L Mishchenko, Ilya R Akberdin, Pavel S Demenkov, Vitaly A Likhoshvai, Konstantin N Kozlov, Dmitry I Todorov, Vitaly V Gursky, Maria G Samsonova, Alexander M Samsonov, Diana Clausznitzer, Lars Kaderali, Nikolay A Kolchanov, Vladimir A Ivanisenko
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2014
Sujets:
Medicine
R
Science
Q
Accès en ligne:https://doaj.org/article/cb38672ba80c44689a4dc650e1639ee7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Documents similaires